Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection.

Journal Article

As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development. For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers,and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.

Full Text

Duke Authors

Cited Authors

  • Clark, PJ; Thompson, AJV; McHutchison, JG

Published Date

  • November 2010

Published In

Volume / Issue

  • 88 / 5

Start / End Page

  • 708 - 711

PubMed ID

  • 20881951

Pubmed Central ID

  • 20881951

Electronic International Standard Serial Number (EISSN)

  • 1532-6535

Digital Object Identifier (DOI)

  • 10.1038/clpt.2010.185

Language

  • eng

Conference Location

  • United States